课题基金 / 基金详情

MECHANISM OF ACTION OF STEROID HORMONES

MECHANISM OF ACTION OF STEROID HORMONES
类固醇激素的作用机制
批准号:
3225551
负责人:
DONALD A YOUNG
金额:
$23.73万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
1978
资助国家:
美国
项目状态:
已结题
起止时间:
1978-08-01 至 1992-07-31

项目摘要

项目成果

DONALD A YOUNG的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
The long-term objectives are to understand the molecular and metabolic events involved in the initiation and implementation of each of the biological effects of adrenal glucocorticoid hormones. We have made progress towards this goal by the discovery of a few (6-11) very rapid inductions of proteins and mRNAs that appear to initiate the hormone effects in each of the normal target tissues; thymus, fat, liver and fibroblastic cells. One of these, glucocortin, is of special interest as the most rapid induction in all target cells. Another, protein 1N may be the physiological inhibitor of glucose transport and/or a member of the lipocortin family. Portions of our continuing investigations are aimed providing more detailed information about these mediators in the different target cells. Studies on induction mechanisms will sort out primary and secondary responses and gather further information about subcellular locations, DNA binding, and structural relationships with other molecules. We will investigate the specificity of individual inductions for a variety of glucocorticoids with aim of possible sub-classifications. We will further investigate functions by observing the actions of the mediators themselves and antibodies to them in subcellar systems. Other work is aimed at the development of oligonucleotide and antibody probes. Then, starting with glucocortin we will undertake molecular cloning. In addition to the structural information gained about these proteins and their genes this will allow the eventual use of expression vectors for the further exploration of their functions in cultured cells. Clinical relevance. The therapeutic benefits that immunosuppressive and anti-inflammatory effects of glucocorticoids offer in chronic disease states, organ transplantation, and cancer chemotherapy are offset by the life- threatening side effects of bone resorption and connective tissue wasting. It seems likely that mediators of the individual glucocorticoid actions themselves or related therapeutic agents derived by genetic engineering will eventually be available to the clinician for the production of desirable actions of glucocorticoids without these unfortunate side effects. These studies will also provide fundamental information about bioregulatory mechanisms in thymus cells; so the fundamental information may eventually have relevance to research on AIDS.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
ACTIONS OF THE P53 TUMOR SUPPRESSOR PROTEINS
  • 批准号:
    2097619
  • 项目类别:
  • 资助金额:
    $20.34万
  • 财政年份:
    1992
  • 负责人:
    DONALD A YOUNG
  • 依托单位:
ACTIONS OF THE P53 TUMOR SUPPRESSOR PROTEINS
  • 批准号:
    3201248
  • 项目类别:
  • 资助金额:
    $21.35万
  • 财政年份:
    1992
  • 负责人:
    DONALD A YOUNG
  • 依托单位:
ACTIONS OF THE P53 TUMOR SUPPRESSOR PROTEINS
  • 批准号:
    3201249
  • 项目类别:
  • 资助金额:
    $20.12万
  • 财政年份:
    1992
  • 负责人:
    DONALD A YOUNG
  • 依托单位:
PAPILLOMA VIRUS ACTIONS ON HOST CELL GENE PRODUCTS
  • 批准号:
    3191409
  • 项目类别:
  • 资助金额:
    $18.14万
  • 财政年份:
    1988
  • 负责人:
    DONALD A YOUNG
  • 依托单位:
海外基金